Información para pacientes
Información para pacientes
Los pacientes son el foco principal en lo que hacemos. Nos preocupamos por usted y su familia, así que hemos recopilado algunos datos importantes acerca de nuestros productos y negocio.
Los medicamentos genéricos pueden ayudarle a ahorrar dinero en cada receta. No todos los fabricantes de productos farmacéuticos ofrecen los mismos productos de calidad y por eso es muy importante que usted tenga la información correcta.
Puede haber pequeñas diferencias en apariencia entre la original y el duplicado, pero el resultado va a ser el mismo, ambas llaves van a encajar en la misma cerradura y a abrir la misma puerta.
HQ/SDZ/16-0001(1)
- European Commission. Consensus Information Paper 2013. What you need to know about Biosimilar Medicinal Products.http://ec.europa.eu/DocsRoom/documents/8242/attachments/1/translations/en/renditions/native(link is external). Accessed March 14, 2016.
-
Information on Biosimilarshttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/Biosimilars/(link is external). Accessed April 27, 2016.
-
European Medicines Agency. Questions and answers on biosimilar medicines (similar biological medicinal products).http://www.ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2009/12/WC500020062.pdf(link is external). Accessed March 14, 2016.
-
IMS Institute, Delivering on the Promise of Biosimilar Medicines: The Role of Functioning Competitive Markets.http://www.imshealth.com/files/web/IMSH%20Institute/Healthcare%20Briefs/Documents/IMS_Institute_Biosimilar_Brief_March_2016.pdf(link is external). Accessed April 27, 2016.
-
Information for Consumers (Biosimilars).http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/Biosimilars/ucm241718.htm(link is external). Accessed April 27, 2016.
-
International Alliance of Patients’ Organizations. Briefing Paper on biological and Biosimilar Medicines. November 2013.https://www.iapo.org.uk/sites/default/files/files/IAPO%20Briefing%20Paper.pdf(link is external). Accessed March 14, 2016.
-
Biosimilars: what clinicians should know. Weise M et al. Blood, 2012; 120 (26): 5111-5117.
-
Guidelines on evaluation of similar biotherapeutic products (SBPs).World Health Organization (2010)http://www.who.int/biologicals/areas/biological_therapeutics/BIOTHERAPEUTICS_FOR_WEB_22APRIL2010.pdf(link is external). Accessed March 14, 2016.
-
European Medicines Agency. European Public Assessment Reports. http://www.ema.europa.eu/ema/index.jsp?curl=pages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=WC0b01ac058001d124&searchTab=searchByAuthType&alreadyLoaded=true&isNewQuery=true&status=Authorised&keyword=Enter+keywords&searchType=name&taxonomyPath=&treeNumber=&searchGenericType=biosimilars&genericsKeywordSearch=Submit(link is external). Accessed April 27, 2016.
-
FDA approves first biosimilar product. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm436648.htm(link is external)